Versiti Blood Health, Inc.Federal contracts and grants
- Milwaukee, WI
- UEI JZDRNT166LE4
USAspending shows $85M in obligations to this recipient in 4 of the 5 fiscal years from FY2023 to FY2027.
The obligations in FY2026 were $16M.
Contracts were $2.7M of the obligations in FY2026.
The obligations in FY2027 to date are under $1 million.
The awards of $1 million or more that started since FY2023 came from 2 agencies.
The largest award value came from the Department of Health and Human Services.
A fiscal year under $1 million is not in the total.
The states where the work of the awards of $1 million or more is done. The swatches go from the smallest award value to the largest. The largest is Wisconsin: $35M.
Wisconsin: the address of the recipient.
The amounts for each state. Outlines: US Census Bureau.
An outlay occurs when federal money is actually paid out, not just promised to be paid ("obligated").
Procurement data (such as for contracts and indefinite delivery vehicles (IDV)) for the Department of Defense (DOD) and U.S. Army Corps of Engineers (USACE) are published on a 90-day delay in the Federal Procurement Data System (FPDS).
Maintaining data quality for the award description field has been persistently challenging for federal agencies.
These are the words of USAspending. Sources: USAspending.gov, About the Data (PDF, last updated 19 November 2025) and USAspending.gov, Glossary. The site copied them on .
The amounts on this page are obligations. An obligation is a promise to pay. It is not a payment. Contract records of the Department of Defense come late, so a recent month can be low. The text under a name in a list of awards is the description that the agency wrote.
USAspending loaded the data on . USAspending profile of this recipient
Since the last update
No change is on record for this page.
The site compares each data load with the load before it. It records a change of the FY2027 obligations when the change is $1 million or more and 10% or more. It also records each new award of $1 million or more.
Obligations by fiscal year
| Fiscal year | All obligations | Contracts | Other awards |
|---|---|---|---|
| FY2023 | $22M | $6.9M | $15M |
| FY2024 | $27M | $6.3M | $20M |
| FY2025 | $21M | $2.4M | $18M |
| FY2026 | $16M | $2.7M | $13M |
| FY2027 to date | under $1 million |
Contracts are the procurement award types. Other awards are grants, direct payments, loans (subsidy cost) and other assistance. The contracts figure shows only when contracts alone are $1 million or more.
Awarding agencies
| Agency | Awards | Award value | Share |
|---|---|---|---|
| Department of Health and Human Services | 11 | $25M | 71% |
| Department of Defense | 3 | $10M | 29% |
Awards
| Awarding agency | Type | Industry or program | Award value | Start date | Place | Record |
|---|---|---|---|---|---|---|
| Department of DefenseDefense Health Agency | GrantProject Grant (B) | 12.420 Military Medical Research and Development | $1.7M | 22 Apr 2026 | WI | USAspending |
| Department of Health and Human ServicesNational Institutes of Health | GrantProject Grant (B) | 93.837 Cardiovascular Diseases Research | $1.1M | 10 Mar 2026 | WI | USAspending |
| Department of Health and Human ServicesNational Institutes of Health | GrantProject Grant (B) | 93.837 Cardiovascular Diseases Research | $1.2M | 23 Jul 2025 | WI | USAspending |
| Department of Health and Human ServicesNational Institutes of Health | GrantProject Grant (B) | 93.395 Cancer Treatment Research | $1.1M | 10 Mar 2025 | WI | USAspending |
| Department of Health and Human ServicesNational Institutes of Health | GrantProject Grant (B) | 93.867 Vision Research | $1.2M | 11 Sep 2024 | WI | USAspending |
| Awarding agency | Type | Industry or program | Award value | Start date | Place | Record |
|---|---|---|---|---|---|---|
| Department of Health and Human ServicesNational Institutes of HealthMOLECULAR MECHANISMS OF IMMUNE THROMBOCYTOPENIA IN TRANSFUSION MEDICINE - OVERALL COMPONENT – PROJECT SUMMARY/ABSTRACT THIS REVISED APPLICATION FOR A PROGRAM ... | GrantProject Grant (B) | 93.837 Cardiovascular Diseases Research | $7.6M | 31 Jul 2024 | WI | USAspending |
| Department of DefenseDefense Health AgencyRESEARCH AND DEVELOPMENT CONTRACT - PROPOSAL JW220021 - CONTRACT PROPOSAL TITLE - EVALUATING THE SAFETY AND EASE OF USE OF COUNTERFLOW HEMOSTATIC GAUZE FOR ... | ContractDefinitive Contract | 541714 Research and Development in Biotechnology (except Nanobiotechnology) | $6.5M | 21 Sep 2023 | WI | USAspending |
| Department of Health and Human ServicesNational Institutes of HealthCD39-CARRYING EXTRACELLULAR VESICLES REGULATE PULMONARY THROMBOSIS IN SICKLE CELL DISEASE - PROJECT SUMMARY SICKLE CELL DISEASE (SCD) IS THE MOST COMMON ... | GrantProject Grant (B) | 93.837 Cardiovascular Diseases Research | $3.1M | 7 Jul 2023 | WI | USAspending |
| Department of Health and Human ServicesNational Institutes of HealthUNDERSTANDING AND CONTROLLING THE CONTRIBUTION OF FIBRINOLYSIS TO BLEEDING USING A LONG-ACTING ANTIFIBRINOLYTIC RNA THERAPY - SUMMARY BACKGROUND: THE BALANCE ... | GrantProject Grant (B) | 93.837 Cardiovascular Diseases Research | $2.9M | 15 Aug 2023 | WI | USAspending |
| Department of Health and Human ServicesNational Institutes of HealthNON-CONVENTIONAL SIGNALING BY Α5 INTEGRIN IN BLOOD AND ENDOTHELIAL CELLS - SUMMARY – INTEGRINS INTERACT WITH THEIR LIGANDS TO INDUCE INTRACELLULAR SIGNALS THAT ... | GrantProject Grant (B) | 93.837 Cardiovascular Diseases Research | $2.2M | 10 Jul 2024 | WI | USAspending |
| Department of DefenseDefense Health AgencyCONTROLLING THROMBOEMBOLISM AFTER POLYTRAUMA WITH AN RNA THERAPY AGAINST EXCESS FIBRINOGEN | GrantProject Grant (B) | 12.420 Military Medical Research and Development | $2.0M | 31 Jul 2024 | WI | USAspending |
| Department of DefenseDefense Health AgencyA COUNTERMEASURE FOR MICROTHROMBOSIS AND TISSUE INJURY IN FREEZING COLD INJURY THAT PREVENTS PATHOLOGIC FIBRINOGEN ELEVATION. | GrantProject Grant (B) | 12.420 Military Medical Research and Development | $1.7M | 22 Apr 2026 | WI | USAspending |
| Department of Health and Human ServicesNational Institutes of HealthREDS-IV-P DOMESTIC HUBS | ContractDelivery Order | 541715 Research and Development in the Physical, Engineering, and Life Sciences (except Nanotechnology and Biotechnology) | $1.7M | 28 Jun 2024 | WI | USAspending |
| Department of Health and Human ServicesNational Institutes of HealthINTERROGATING CLINICALLY RELEVANT ATTRIBUTES OF MATERNAL ALLOIMMUNITY IN FETAL/NEONATAL ALLOIMMUNE THROMBOCYTOPENIA - ABSTRACT IMMUNE RESPONSES TO PLATELET ... | GrantProject Grant (B) | 93.837 Cardiovascular Diseases Research | $1.4M | 25 Apr 2024 | WI | USAspending |
| Department of Health and Human ServicesNational Institutes of HealthTHE FUNCTION OF MS4A3 IN NORMAL AND MALIGNANT HEMATOPOIESIS - CHRONIC MYELOID LEUKEMIA (CML) IS CAUSED BY BCR-ABL1, A CONSTITUTIVELY ACTIVE TYROSINE KINASE ... | GrantProject Grant (B) | 93.396 Cancer Biology Research | $1.3M | 30 Dec 2022 | WI | USAspending |
| Department of Health and Human ServicesNational Institutes of HealthMEMBRANE-CYTOSKELETON INTERACTIONS IN MEGAKARYOCYTES AND PLATELETS - PROJECT ABSTRACT ABNORMAL PLATELET PRODUCTION AND FUNCTION, DUE TO GENETIC FACTORS, CANCER ... | GrantProject Grant (B) | 93.837 Cardiovascular Diseases Research | $1.2M | 23 Jul 2025 | WI | USAspending |
| Department of Health and Human ServicesNational Institutes of HealthENDOTHELIAL RAP1 RESTRICTS INFLAMMATION IN THE RETINA - PROJECT SUMMARY ENDOTHELIAL-LEUKOCYTE INTERACTIONS ARE PIVOTAL IN DIABETIC RETINOPATHY (DR), A MAJOR ... | GrantProject Grant (B) | 93.867 Vision Research | $1.2M | 11 Sep 2024 | WI | USAspending |
Industries, programs and places of performance
| Industry | Awards | Award value |
|---|---|---|
| 541714 Research and Development in Biotechnology (except Nanobiotechnology) | 1 | $6.5M |
| 541715 Research and Development in the Physical, Engineering, and Life Sciences (except Nanotechnology and Biotechnology) | 1 | $1.7M |
| Assistance listing | Awards | Award value |
|---|---|---|
| 93.837 Cardiovascular Diseases Research | 7 | $19M |
| 12.420 Military Medical Research and Development | 2 | $3.7M |
| 93.396 Cancer Biology Research | 1 | $1.3M |
| 93.867 Vision Research | 1 | $1.2M |
| 93.395 Cancer Treatment Research | 1 | $1.1M |
| State | Awards | Award value |
|---|---|---|
| Wisconsin | 14 | $35M |
The counties with the largest award value, largest first.
Other recipients of about the same size
Recipients in the same NAICS sector, with an address in Wisconsin. In order of name. These recipients have obligations nearest to those of Versiti Blood Health, Inc. in the listed fiscal years.
- Advancia Aeronautics, LLCMilwaukee, WI
- CCS Lintech JV LLCMilwaukee, WI
- Clear Global Solutions LLCScandinavia, WI
- Command Cyber Solutions LLCMilwaukee, WI
- Eaton CorporationMenomonee Falls, WI
- Flexion IncMadison, WI
- Industries for the Blind and Visually Impaired, Inc.West Allis, WI
- Johnson Controls Government Systems, LLCRockville, WI
- Marshfield Clinic, Inc.Marshfield, WI
- Optumserve Technology Services, Inc.Columbia, WI
- Potawatomi Training LLCMilwaukee, WI
- Superior Health Quality Alliance IncMadison, WI
All recipients in Wisconsin, in order of name.
Official records
- USAspending profile of this recipientUSAspending.gov. The official record of the awards to this recipient (UEI JZDRNT166LE4).
- SAM.gov entity searchSAM.gov, U.S. General Services Administration. The search of entity registrations by name or UEI.
- USAspending advanced searchUSAspending.gov. The search of all award records, with filters for recipient, agency, place and time period.
Each link opens a page of a federal agency in a new tab. The site examined the links on .
Cite this page
Fed Spend Map. "Versiti Blood Health, Inc.: federal contracts and grants". Data: USAspending.gov, U.S. Department of the Treasury, Bureau of the Fiscal Service, loaded .
https://fedspendmap.com/recipient/jzdrnt166le4-versiti-blood-health-inc/
The address of this page is permanent.
Where the figures come from
USAspending.gov API v2 (U.S. Department of the Treasury, Bureau of the Fiscal Service). Fiscal year obligations: the list of recipients by state, with a listing floor of $1 million for each year. Awards: the award search, new awards of $1 million or more by base obligation date. Parent and business types: the recipient profile.
USAspending loaded the data on 30 Sep 2026. A closed fiscal year is a copy made after the year end. The site shows organisations only. The site corrects an error in its own work at the next build. See how to report an error and how the atlas is made.
Questions
Which fiscal years are in the total?
The total has 4 fiscal years.
- FY2023: $22M
- FY2024: $27M
- FY2025: $21M
- FY2026: $16M
- FY2027 to date: under $1 million
The site lists a fiscal year of a recipient when the obligations of the year are $1 million or more.
Which industries and programs do the awards name?
The contract awards of $1 million or more name 2 NAICS industries.
The largest award value is in NAICS 541714, Research and Development in Biotechnology (except Nanobiotechnology): $6.5M.
The assistance awards name 5 assistance listings.
The largest award value is in listing 93.837, Cardiovascular Diseases Research: $19M.
Where is the place of performance?
The awards of $1 million or more name 1 state as the place of performance.
The largest award value is in Wisconsin: $35M.
The place of performance is where the work is done. It is not always the address of the recipient.
How many awards are in the lists on this page?
The lists hold 14 awards of $1 million or more that started in FY2023 or later.
Their award value is $35M.
An award under that amount is in the obligations of the fiscal years but not in the lists.